Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB Trial).
| Image |  |
|---|---|
| Description | scientific article published in April 2008 |
| Author/s |
author: Pierfranco Conte Federico Piacentini |
| Publication date | April 1, 2008 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |